{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:07:24Z","timestamp":1786990044783,"version":"build-2736575974"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.gore.2026.102025","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:26:32Z","timestamp":1767860792000},"page":"102025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Early-stage sertoliform endometrioid carcinoma of the ovary: diagnostic, molecular, and therapeutic considerations"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0160-7731","authenticated-orcid":false,"given":"Janhvi","family":"Sookram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin B.","family":"Gilchrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.gore.2026.102025_b0005","first-page":"1254","article-title":"Sertoliform endometrioid carcinoma of the ovary: a clinicopathologic analysis of a distinctive variant","volume":"30","author":"Eichhorn","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.gore.2026.102025_b0010","first-page":"675","article-title":"Ovarian endometrioid carcinoma: clinicopathologic features and diagnostic challenges","volume":"57","author":"Lim","year":"2010","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.gore.2026.102025_b0015","first-page":"93","article-title":"Pathology of ovarian carcinomas: classification and molecular insights","volume":"34","author":"D\u2019Angelo","year":"2015","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.gore.2026.102025_b0020","first-page":"45","article-title":"Low-grade endometrioid ovarian carcinoma: patterns of care and survival outcomes","volume":"13","author":"Matsuo","year":"2020","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.gore.2026.102025_b0025","unstructured":"WHO Classification of Female Genital Tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2020."},{"key":"10.1016\/j.gore.2026.102025_b0030","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer. Version 2024."},{"issue":"3","key":"10.1016\/j.gore.2026.102025_b0035","first-page":"579","article-title":"Prognostic factors for high-risk early-stage epithelial ovarian cancer","volume":"112","author":"Chan","year":"2008","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.gore.2026.102025_b0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jcp.2007.049478","article-title":"My approach to the typing of ovarian carcinomas","volume":"61","author":"McCluggage","year":"2008","journal-title":"J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.gore.2026.102025_b0045","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ygyno.2012.02.037","article-title":"Hormonal therapy for recurrent low-grade serous carcinoma of the ovary","volume":"125","author":"Gershenson","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.gore.2026.102025_b0050","first-page":"245","article-title":"Phase II study of letrozole in patients with recurrent endometrial carcinoma","volume":"138","author":"Slomovitz","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.gore.2026.102025_b0055","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P","article-title":"\u03b2-catenin signaling and cancer","volume":"21","author":"Morin","year":"1999","journal-title":"Bioessays"},{"issue":"1","key":"10.1016\/j.gore.2026.102025_b0060","first-page":"49","article-title":"Ovarian endometrioid carcinoma: molecular analysis reveals distinct low-grade and high-grade subgroups","volume":"234","author":"McConechy","year":"2014","journal-title":"J. Pathol."},{"issue":"34","key":"10.1016\/j.gore.2026.102025_b0065","first-page":"4353","article-title":"Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities","volume":"33","author":"Davis","year":"2014","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.gore.2026.102025_b0070","first-page":"147","article-title":"Personalized circulating tumor DNA biomarkers dynamically predict treatment response and survival in gynecologic cancers","volume":"161","author":"Pereira","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2026.102025_b0075","article-title":"Utility of circulating tumor DNA in ovarian cancer management: current status and future perspectives","volume":"102","author":"Zhang","year":"2022","journal-title":"Cancer Treat. Rev."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578926000056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578926000056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:22:50Z","timestamp":1771662170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578926000056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":15,"alternative-id":["S2352578926000056"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2026.102025","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early-stage sertoliform endometrioid carcinoma of the ovary: diagnostic, molecular, and therapeutic considerations","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2026.102025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102025"}}